VBI Vaccines
VBIV
$0.58
Share price
2.30%
Change (1 day)
-79.84%
Change (1 year)
Categories
VBI Vaccines (VBIV) - Total debt
Total debt on the balance sheet as of December 2023 : $53.04 M
According to VBI Vaccines 's latest financial reports the company's total debt is $53.04 M. A company’s total debt is the sum of all current and non-current debts.
VBI Vaccines - Total debt on balance sheet (from 2004 to 2023)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2022-12-31 | $52.22 M | 64.25% |
| 2021-12-31 | $31.79 M | 77.71% |
| 2020-12-31 | $17.89 M | 9.74% |
| 2019-12-31 | $16.3 M | 16.23% |
| 2018-12-31 | $14.02 M | 6.77% |
| 2017-12-31 | $13.13 M | 9.89% |
| 2016-12-31 | $11.95 M | |
| 2005-03-31 | $0.16 M | 34.09% |
| 2004-03-31 | $0.12 M |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 Onconova Therapeutics ONTX | N/A | N/A | 🇺🇸 USA |
 Curis CRIS | $2.79 M | -94.73% | 🇺🇸 USA |
 Myriad Genetics MYGN | $0.15 B | 186.76% | 🇺🇸 USA |